tiprankstipranks
Satellos Bioscience (TSE:MSCL)
TSX:MSCL
Canadian Market
MSCL
Satellos Bioscience
RESEARCH TOOLSreports

Satellos Bioscience (MSCL) Financial Statements

30 Followers

Satellos Bioscience Financial Overview

Satellos Bioscience's market cap is currently C$171.86M. The company's EPS TTM is C$-0.694; its P/E ratio is -4.57; Satellos Bioscience is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Mar 23Mar 22
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -5.09KC$ -20.00KC$ -8.82MC$ -3.73MC$ -119.92K
Operating IncomeC$ -26.92MC$ -27.81MC$ -15.46MC$ -8.43MC$ -4.74M
EBITDAC$ -26.92MC$ -28.08MC$ -15.71MC$ -8.09MC$ -4.60M
Net IncomeC$ -25.31MC$ -28.10MC$ -15.89MC$ -11.32MC$ -15.51M
Balance Sheet
Cash & Short-Term InvestmentsC$ 27.66MC$ 69.85MC$ 39.59MC$ 1.92MC$ 4.87M
Total AssetsC$ 31.83MC$ 73.02MC$ 44.30MC$ 6.20MC$ 12.59M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -9.79MC$ -57.66MC$ -22.07MC$ -1.92MC$ -4.87M
Total LiabilitiesC$ 4.10MC$ 5.16MC$ 3.62MC$ 2.83MC$ 2.10M
Stockholders' EquityC$ 27.73MC$ 67.86MC$ 40.67MC$ 3.37MC$ 10.48M
Cash Flow
Free Cash FlowC$ -24.02MC$ -24.98MC$ -14.52MC$ -5.79MC$ -5.04M
Operating Cash FlowC$ -24.01MC$ -24.98MC$ -14.50MC$ -5.78MC$ -5.03M
Investing Cash FlowC$ -9.58MC$ 6.34MC$ -17.54MC$ -3.00KC$ 1.74M
Financing Cash FlowC$ 2.28MC$ 53.48MC$ 51.03MC$ 2.77MC$ 7.45M
Currency in CAD

Satellos Bioscience Earnings and Revenue History

Income Statement >

Satellos Bioscience Debt to Assets

Balance Sheet >

Satellos Bioscience Cash Flow

Cash Flow >

Satellos Bioscience Forecast EPS vs Actual EPS

Earnings >